JTC-801 is a potent and selective nociceptin/orphanin FQ peptide (NOP) receptor antagonist (IC50 = 94 nM) with weak activity at classical opioid receptors. It is a valuable research tool for investigating pain pathways and has been utilized in both in vitro and in vivo studies of nociception and analgesia.